SEC 13F Intelligence

Sofinnova Investments, Inc. / DYN

Sofinnova Investments, Inc.’s Dyne Therapeutics Inc Position

Does Sofinnova Investments, Inc. own Dyne Therapeutics Inc (DYN)? Yes — 1.63M shares worth $30M (+1.13% of its 13F portfolio) as of Q1 2026, down from 2.25M shares the prior filed quarter.

Position Value
$30M
Q1 2026
Shares
1.63M
% of Portfolio
+1.13%
Quarters Held
12
currently held

Position History DYN

Reported value by quarter
Q2 ’23: $5MQ2 ’23Q3 ’23: $6MQ4 ’23: $13MQ4 ’23Q1 ’24: $55MQ2 ’24: $13MQ2 ’24Q3 ’24: $28MQ4 ’24: $25MQ4 ’24Q1 ’25: $7MQ2 ’25: $6MQ2 ’25Q3 ’25: $12MQ4 ’25: $44MQ4 ’25Q1 ’26: $30Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.63M$30M+1.13%
Q4 20252.25M$44M+1.90%
Q3 2025985.8K$12M+0.68%
Q2 2025614.9K$6M+0.36%
Q1 2025716.9K$7M+0.49%
Q4 20241.07M$25M+1.84%
Q3 2024772.1K$28M+2.20%
Q2 20241.01M$13M+0.75%
Q1 20241.94M$55M+3.06%
Q4 20231.01M$13M+0.75%
Q3 2023685.1K$6M+0.39%
Q2 2023441.0K$5M+0.32%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sofinnova Investments, Inc.’s full portfolio or all institutional holders of DYN.